Clover Health Investments 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Clover Health Investments 's ROA in the second quarter of 2026?
Clover Health Investments Corp recorded a cumulative net loss of $-18 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -2.91%.

However, within the Financial sector 851 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3172, from total ROA ranking in the first quarter of 2026 at 3927.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	25.28 %	19.53 %	-30.63 %	-33.14 %	-26.02 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-18	-57	-86	-58	-43
Return On Assets (TTM)	-2.91 %	-9.59 %	-15.13 %	-9.33 %	-6.21 %
CLOV's Total Ranking	# 3172	# 3927	# 3291	# 3158	# 2999
Total Assets (TTM) in million	720	698	543	560	575
Seq. Total Assets Change	3.24 %	28.55 %	-3.01 %	-2.67 %	-1.5 %
Seq. Net Income Change	2.44 %	-	-	-	-

CLOV's 5 Years Annual ROA >> Back to CLOV Management Effectiveness >> Compare CLOV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 12
Sector	# 852
Overall	# 2818

Return On Assets Statistics
High	Average	Low
-2.92 %	-22.09 %	-58.98 %
(Jun 30 2026)		(Dec 31 2021)

Financial Statements
Clover Health Investments 's Assets	$ 720 million	CLOV's Balance sheet
Clover Health Investments 's Income	$ 28 million	Quarterly CLOV's Income Statement
CLOV's Income by Division		See CLOV's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-6.95 %	13.26 %	-26.97 %	-0.51 %	11.02 %
Total Assets in million	728	782	691	946	951
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-86	-43	-213	-339	-588
Annual Return On Assets	-11.75 %	-5.5 %	-30.88 %	-35.82 %	-61.82 %

CLOV's 5 Years Annual ROA >> Back to CLOV Management Effectiveness >> Compare CLOV ROA to its Competitors

More Return On Assets Ratios
CLOV's' Return on Assets at Yahoo Finance
Accident & Health Insurance Industry Return On Assets Trends and Statistics
Financial Sector Roa Statistics
Roa Trends for overall market
CLOV's Roa Ratio versus Accident & Health Insurance Industry, Financial Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CLOV's Competitors
Subscribers only: Roa for Clover Health Investments 's Suppliers
Subscribers only: Return On Assets for CLOV's Customers

You may also want to know
CLOV's Roi	CLOV's Inventory Turnover Ratio	CLOV's Growth Rates	CLOV's Dividend Comparisons
	CLOV's Profitability Ratios	CLOV's Asset Turnover Ratio	CLOV's Dividend Growth
CLOV's Roe	CLOV's Valuation Ratios	CLOV's Financial Strength Ratios	CLOV's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Financial Sector

ROA

Date modified: 2026-08-14T09:21:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.